AETHLON MEDICAL, INC. (AEMD) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2024-03-31..
Gross margin
Overview →Financial period ending 2024-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2024-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 0.00 USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2024-03-31 | (m) | $0.00 | (m) | (m) |
| 2023-03-31 | (m) | $574.25K | (m) | (m) |
| 2022-12-31 | (m) | $13.12K | (m) | (m) |
| 2022-09-30 | (m) | $30.23K | (m) | (m) |
| 2022-06-30 | (m) | $162.20K | (m) | (m) |
| 2022-03-31 | (m) | $294.17K | (m) | (m) |
| 2021-12-31 | (m) | $315.28K | (m) | (m) |
| 2021-09-30 | (m) | $923.04K | (m) | (m) |
| 2021-06-30 | (m) | $791.07K | (m) | (m) |
| 2021-03-31 | (m) | $659.10K | (m) | (m) |
| 2020-12-31 | (m) | $831.60K | (m) | (m) |
| 2020-09-30 | (m) | $620.19K | (m) | (m) |
| 2020-06-30 | (m) | $620.19K | (m) | (m) |
| 2020-03-31 | (m) | $650.19K | (m) | (m) |
| 2019-12-31 | (m) | $523.46K | (m) | (m) |
| 2019-09-30 | (m) | $110.00K | (m) | (m) |
| 2019-06-30 | (m) | $110.00K | (m) | (m) |
| 2019-03-31 | (m) | $229.63K | (m) | (m) |
| 2018-12-31 | (m) | $224.44K | (m) | (m) |
| 2018-09-30 | (m) | $299.25K | (m) | (m) |
| 2018-06-30 | (m) | $299.25K | (m) | (m) |
| 2018-03-31 | (m) | $149.63K | (m) | (m) |
| 2017-12-31 | (m) | $74.81K | (m) | (m) |
| 2017-09-30 | (m) | $0.00 | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $392.07K | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $886.57K | (m) | (m) |
| 2015-03-31 | (m) | $762.42K | (m) | (m) |
| 2014-12-31 | (m) | $1.27M | (m) | (m) |
| 2014-09-30 | (m) | $1.31M | (m) | (m) |
| 2014-06-30 | (m) | $1.48M | (m) | (m) |
| 2014-03-31 | (m) | $1.62M | (m) | (m) |
| 2013-12-31 | (m) | $1.32M | (m) | (m) |
| 2013-09-30 | (m) | $1.45M | (m) | (m) |
| 2013-06-30 | (m) | $1.21M | (m) | (m) |
| 2013-03-31 | (m) | $1.23M | (m) | (m) |
| 2012-12-31 | (m) | $1.23M | (m) | (m) |
| 2012-09-30 | (m) | $1.98M | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $1.36M | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |